Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Kirkpatrick

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
The Journal of Biological Chemistry|September 6, 2000
Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte functionY Ji, M J Lalli, G J Babu, et al.
Investigational New Drugs|June 20, 2012
A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancersA F Baker, K N Adab, N Raghunand, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
The Journal of Biological Chemistry|September 6, 2000
Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte functionY Ji, M J Lalli, G J Babu, et al.
Investigational New Drugs|June 20, 2012
A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancersA F Baker, K N Adab, N Raghunand, et al.
Pageof 5